AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimkaire MF 1mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

SAG Health Science Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Glimkaire MF 1mg/1000mg Tablet SR

DiaBeta-Duo 1mg/1000mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta-Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication as prescribed, even if you feel well or your blood sugar is controlled. Discontinuing treatment without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan that includes a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms, such as sweating, lightheadedness, headache, and tremors, and know how to manage them. Regular meals and carrying a fast-acting glucose source, like sugary snacks or juice, are crucial for prevention. Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or breastfeeding individuals should consult their physician prior to use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to monitor blood cell counts and liver function.

Primary Ingredients of Glimkaire MF 1mg/1000mg Tablet SR

There is no text provided to rephrase.

Uses of Glimkaire MF 1mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimkaire MF 1mg/1000mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimkaire MF 1mg/1000mg Sustained-Release tablets should be taken with meals.

Common Side effects of Glimkaire MF 1mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimkaire MF 1mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Glimkaire MF 1mg/1000mg Sustained-Release Tablet with a meal.

How Glimkaire MF 1mg/1000mg Tablet SR works:

Glimkaire MF 1mg/1000mg Extended-Release Tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimkaire MF 1mg/1000mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimkaire MF 1mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimkaire MF tablets (1mg/1000mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimkaire MF 1mg/1000mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glimkaire MF 1mg/1000mg SR tablets. Consult a physician. Regular assessment of kidney function is recommended during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Glimkaire MF 1mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. Low initial doses are typically prescribed for individuals with mild to moderate hepatic dysfunction; however, Glimkaire MF 1mg/1000mg Tablet SR is contraindicated in those with severe liver disease.

What if you forget to take Glimkaire MF 1mg/1000mg Tablet SR :

Should you forget a dose of Glimkaire MF 1mg/1000mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimkaire MF 1mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimkaire MF 1mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimkaire MF 1mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimkaire MF 1mg/1000mg Tablet SR and seek immediate medical attention.
Glimkaire MF 1mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 DM.
Glimkaire MF 1mg/1000mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimkaire MF 1mg/1000mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimkaire MF 1mg/1000mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimkaire MF 1mg/1000mg SR tablets with alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimkaire MF 1mg/1000mg T...
57
MRP 70
18% off